MedTrace Logo

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

NCT00914043 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2013-01-11

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to fatigue.

PURPOSE: This research study is looking at biological markers of fatigue in women with residual invasive breast cancer enrolled on clinical trial NSABP-B-45.

Conditions

Interventions

GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

polymerase chain reaction

GENETIC

polymorphism analysis

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

biologic sample preservation procedure

OTHER

enzyme-linked immunosorbent assay

OTHER

laboratory biomarker analysis

PROCEDURE

fatigue assessment and management

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • NSABP Foundation Inc

    lead NETWORK

Principal Investigators

  • Norman Wolmark, MD · NSABP Foundation Inc

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2010-06-30
Completion
2010-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00914043 on ClinicalTrials.gov